Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate CalciMedica, Inc. before investing.

In this article, we go over a few key elements for understanding CalciMedica, Inc.’s stock price such as:

• CalciMedica, Inc.’s current stock price and volume
• Why CalciMedica, Inc.’s stock price changed recently
• Upgrades and downgrades for CALC from analysts
• CALC’s stock price momentum as measured by its relative strength

About CalciMedica, Inc. (CALC)

Before we jump into CalciMedica, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. The company also develops Auxora for the treatment of ulcerative colitis, traumatic brain injury, and allergic asthma; and oral CRAC channel inhibitors for use in chronic inflammatory and immunologic disease. The company is based in La Jolla, California.

Want to learn more about CalciMedica, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about CalciMedica, Inc..

CalciMedica, Inc.’s Stock Price as of Market Close

As of July 10, 2026, 4:00 PM, CST, CalciMedica, Inc.’s stock price was $0.930.

CalciMedica, Inc. is down 2.09% from its previous closing price of $0.950.

During the last market session, CalciMedica, Inc.’s stock traded between $0.886 and $0.950. Currently, there are approximately 15.82 million shares outstanding for CalciMedica, Inc..

CalciMedica, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

CalciMedica, Inc. Stock Price History

CalciMedica, Inc.’s (CALC) price is currently down 9.71% so far this month.

During the month of July, CalciMedica, Inc.’s stock price has reached a high of $1.150 and a low of $0.870.

Over the last year, CalciMedica, Inc. has hit prices as high as $7.200 and as low as $0.461. Year to date, CalciMedica, Inc.’s stock is down 85.89%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused CalciMedica, Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 10, 2026, there were analysts who downgraded CalciMedica, Inc.’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate CalciMedica, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on CalciMedica, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about CalciMedica, Inc. (CALC) by visiting AAII Stock Evaluator.

Relative Price Strength of CalciMedica, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 10, 2026, CalciMedica, Inc. has a weighted four-quarter relative price strength of 25.82%, which translates to a Momentum Score of 93 and is considered to be Very Strong.

Want to learn more about how CalciMedica, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

CalciMedica, Inc. Stock Price: Bottom Line

As of July 10, 2026, CalciMedica, Inc.’s stock price is $0.930, which is down 2.09% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like CalciMedica, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.